Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Inebilizumab

Product Specifications

CAS Number

1299440-37-1

Target

Immunology/Inflammation related, ADC Antibody

Related Pathways

Immunology/Inflammation, Antibody-drug Conjugate/ADC Related

Purity

0.993

Bioactivity

Inebilizumab is a humanized anti-CD19 monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used to treat a range of autoimmune diseases associated with CD19 B cells, such as multiple sclerosis and optic neuromyelitis.

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Human MBD4 activation kit by CRISPRa
GA105951 1 Kit

Human MBD4 activation kit by CRISPRa

Sign In for Pricing
View Details
PRDX6 Antibody
orb1258327 100 µL

PRDX6 Antibody

Sign In for Pricing
View Details
Araf 3'UTR Luciferase Stable Cell Line
TU102006 1.0 mL

Araf 3'UTR Luciferase Stable Cell Line

Sign In for Pricing
View Details
Recombinant Human Granulocyte-macrophage colony-stimulating factor protein (CSF2) (Active)
MBS969326-01 0.005 mg

Recombinant Human Granulocyte-macrophage colony-stimulating factor protein (CSF2) (Active)

Sign In for Pricing
View Details
Recombinant Human Granulocyte-macrophage colony-stimulating factor protein (CSF2) (Active)
MBS969326-02 0.1 mg

Recombinant Human Granulocyte-macrophage colony-stimulating factor protein (CSF2) (Active)

Sign In for Pricing
View Details
Recombinant Human Granulocyte-macrophage colony-stimulating factor protein (CSF2) (Active)
MBS969326-03 0.5 mg

Recombinant Human Granulocyte-macrophage colony-stimulating factor protein (CSF2) (Active)

Sign In for Pricing
View Details